Research Programs Cancer Biology & Genetics Cell Biology Computational Biology Developmental Biology Immunology Molecular Biology David Allis @ Rockefeller.edu Robert Fisher Jerard Hurwitz Prasad Jallepalli Scott Keeney Thomas J. Kelly Andrew Koff Kenneth J. Marians John Petrini Mark Ptashne Stewart Shuman Paul Tempst Iestyn Whitehouse Xiaolan Zhao Joint Appointees Simon N. Powell Molecular Pharmacology & Chemistry Structural Biology Postdoctoral Training Graduate Education Summer Undergraduate Research Program Core Facilities Collaborative Research Centers Sloan-Kettering Institute > Research Programs > Molecular Biology > Andrew Koff > Projects > Why is p27 Loss Prognostic for Tumor Development? Selected Publications Park MS, Rosai J, Nguyen HT, Capodieci P, Cordon-Cardo C, and Koff A. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proc. Natl. Acad Sci. USA 96: 6382-6387, 1999. Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, et al. Distinct altered patterns of p27Kip expression in benign prostatic hyperplasia and prostatic carcinoma. J. Natl Canc Inst. 90: 1284-1291, 1998. Return to Why is p27 Loss Prognostic for Tumor Development? Main Page

Memorial Sloan-Kettering Cancer Center | Sloan-Kettering Institute Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center

Site Map | Index	Legal Disclaimer | Privacy Practices | Public Notices
©2008 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org